These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7974497

  • 21. Inhalation toxicokinetics of butoxyethanol and its metabolite butoxyacetic acid in the male Sprague-Dawley rat.
    Johanson G.
    Arch Toxicol; 1994; 68(9):588-94. PubMed ID: 7998827
    [Abstract] [Full Text] [Related]

  • 22. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats.
    Borghoff SJ, Murphy JE, Medinsky MA.
    Fundam Appl Toxicol; 1996 Apr; 30(2):264-75. PubMed ID: 8812274
    [Abstract] [Full Text] [Related]

  • 23. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [Abstract] [Full Text] [Related]

  • 24. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
    Sweeney RE, Langenberg JP, Maxwell DM.
    Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
    [Abstract] [Full Text] [Related]

  • 25. Effects of 2-butoxyethanol on hepatic oxidative damage.
    Park J, Kamendulis LM, Klaunig JE.
    Toxicol Lett; 2002 Jan 05; 126(1):19-29. PubMed ID: 11738267
    [Abstract] [Full Text] [Related]

  • 26. The development of forestomach tumours in the mouse following exposure to 2-butoxyethanol by inhalation: studies on the mode of action and relevance to humans.
    Green T, Toghill A, Lee R, Moore R, Foster J.
    Toxicology; 2002 Dec 02; 180(3):257-73. PubMed ID: 12393295
    [Abstract] [Full Text] [Related]

  • 27. A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human.
    Gargas ML, Tyler TR, Sweeney LM, Corley RA, Weitz KK, Mast TJ, Paustenbach DJ, Hays SM.
    Toxicol Appl Pharmacol; 2000 May 15; 165(1):53-62. PubMed ID: 10814553
    [Abstract] [Full Text] [Related]

  • 28. Free and total urinary 2-butoxyacetic acid following dermal and inhalation exposure to 2-butoxyethanol in human volunteers.
    Kezic S, Meuling WJ, Jakasa I.
    Int Arch Occup Environ Health; 2004 Nov 15; 77(8):580-6. PubMed ID: 15688250
    [Abstract] [Full Text] [Related]

  • 29. Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol.
    Palkar PS, Philip BK, Reddy RN, Mehendale HM.
    Toxicol Appl Pharmacol; 2007 Nov 15; 225(1):102-12. PubMed ID: 17850838
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
    Clarke DO, Elswick BA, Welsch F, Conolly RB.
    Toxicol Appl Pharmacol; 1993 Aug 15; 121(2):239-52. PubMed ID: 8346541
    [Abstract] [Full Text] [Related]

  • 31. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2001 Jul 15; (499):7-340. PubMed ID: 12087422
    [Abstract] [Full Text] [Related]

  • 32. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):352-9. PubMed ID: 17324392
    [Abstract] [Full Text] [Related]

  • 33. Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice.
    Singh P, Morris B, Zhao S, Blaylock BL.
    Int J Toxicol; 2002 Mar 20; 21(2):107-14. PubMed ID: 12022630
    [Abstract] [Full Text] [Related]

  • 34. NTP technical report on the toxicity studies of Ethylene Glycol Ethers: 2-Methoxyethanol, 2-Ethoxyethanol, 2-Butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76-2) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
    Dieter M.
    Toxic Rep Ser; 1993 Jul 20; 26():1-G15. PubMed ID: 12209180
    [Abstract] [Full Text] [Related]

  • 35. Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: II. Resistance in red blood cells from humans with potential susceptibility.
    Udden MM.
    J Appl Toxicol; 1994 Jul 20; 14(2):97-102. PubMed ID: 8027514
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans.
    Udden MM, Patton CS.
    J Appl Toxicol; 1994 Jul 20; 14(2):91-6. PubMed ID: 8027513
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.